Your browser doesn't support javascript.
loading
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).
Uematsu, Shinya; Kitazono, Satoru; Tanaka, Hisashi; Saito, Ryota; Kawashima, Yosuke; Ohyanagi, Fumiyoshi; Tozuka, Takehiro; Ryosuke, Tsugitomi; Sakatani, Toshio; Horiike, Atsushi; Yoshizawa, Takahiro; Saiki, Masafumi; Tambo, Yuichi; Koyama, Junji; Kanazu, Masaki; Kudo, Keita; Tsuchiya-Kawano, Yuko; Yanagitani, Noriko; Nishio, Makoto.
Afiliação
  • Uematsu S; Department of Respiratory Medicine, Osaka Red Cross Hospital, Osaka, Japan.
  • Kitazono S; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Saito R; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Japan.
  • Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Ohyanagi F; Department of Respiratory Medicine, Saitama Cancer Center, Saitama, Japan.
  • Tozuka T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Ryosuke T; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sakatani T; Division of Respiratory, NTT Medical Center, Tokyo, Japan.
  • Horiike A; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Yoshizawa T; Department of Respiratory Medicine, Toho University School of Medicine, Tokyo, Japan.
  • Saiki M; Department of Respiratory Medicine, Graduate School of Medicine University of Yamanashi, Yamanashi, Japan.
  • Tambo Y; Department of Respiratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Koyama J; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kanazu M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
  • Kudo K; Department of Medical Oncology and Respiratory Medicine, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan.
  • Tsuchiya-Kawano Y; Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
  • Yanagitani N; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Thorac Cancer ; 14(2): 168-176, 2023 01.
Article em En | MEDLINE | ID: mdl-36408699
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão